Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03515629
What this trial is testing

REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Regeneron Pharmaceuticals 5
Early research (Phase 1)Study completedNCT05821231
What this trial is testing

Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Institut Claudius Regaud 14
Testing effectiveness (Phase 2)Study completedNCT03816553
What this trial is testing

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaMetastatic Cervical Cancer
Sun Yat-sen University 45
Testing effectiveness (Phase 2)Study completedNCT04004572
What this trial is testing

Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Rong Tao 37
Testing effectiveness (Phase 2)UnknownNCT02942329
What this trial is testing

Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

Who this might be right for
Gastric CancerHepatocellular Carcinoma
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 60
Not applicableNot Yet RecruitingNCT07724951
What this trial is testing

The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 400
Testing effectiveness (Phase 2)Study completedNCT03250273
What this trial is testing

A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma

Who this might be right for
Metastatic CholangiocarcinomaCholangiocarcinomaPancreatic Cancer+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Testing effectiveness (Phase 2)UnknownNCT03989310
What this trial is testing

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Chinese PLA General Hospital 50
Early research (Phase 1)Looking for participantsNCT07476326
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Who this might be right for
Melanoma
Biocon Biologics UK PLC 120
Testing effectiveness (Phase 2)Looking for participantsNCT04299581
What this trial is testing

Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Testing effectiveness (Phase 2)Study completedNCT04510064
What this trial is testing

Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial

Who this might be right for
Metastatic Gastric CancerLocally Advanced Gastric AdenocarcinomaGastric Cancer Adenocarcinoma Metastatic
Fudan University 40
Testing effectiveness (Phase 2)UnknownNCT04096911
What this trial is testing

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsCervical CancerCervical Neoplasms+1 more
Buhai Wang 20
Early research (Phase 1)Active Not RecruitingNCT02715284
What this trial is testing

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
Tesaro, Inc. 729
Not applicableNot Yet RecruitingNCT06504875
What this trial is testing

Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
The First Affiliated Hospital with Nanjing Medical University 23
Testing effectiveness (Phase 2)Study completedNCT03983057
What this trial is testing

Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Zhejiang University 392
Testing effectiveness (Phase 2)UnknownNCT04866381
What this trial is testing

An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 Antibody

Who this might be right for
Esophageal Squamous Cell CarcinomaProgression to PD-1 Antibody
Tianjin Medical University Cancer Institute and Hospital 87
Testing effectiveness (Phase 2)Study completedNCT06908031
What this trial is testing

SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer

Who this might be right for
Rectal AdenocarcinomaHigh-Risk CancerMSS
Sixth Affiliated Hospital, Sun Yat-sen University 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064902
What this trial is testing

Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 48
Not applicableLooking for participantsNCT07586891
What this trial is testing

Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma

Who this might be right for
Melanoma (Skin Cancer)
Xijing Hospital 80
Large-scale testing (Phase 3)Looking for participantsNCT06926868
What this trial is testing

Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Who this might be right for
Breast Neoplasms
Bristol-Myers Squibb 600
Next Page